Safety and Effectiveness of Propagermanium in Diabetic Kidney Disease Participants Receiving Irbesartan
Clinical trial NCT03627715 · COMPLETED
Trial details
- NCT number
- NCT03627715
- Sponsor
- Dimerix Bioscience Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2020-07-23
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.